Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Germany”
- An Outpatient Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous UrticariaRecruiting
Sponsor: ARS Pharmaceuticals, Inc.
Urticaria Chronic
United States, Germany
Sponsor: Celgene
Carcinoma, Non-Small-Cell Lung
United States, France, Germany, Greece, Italy +1 more
Sponsor: Pfizer
Advanced/Metastatic Non-Small Cell Lung Cancer · Carcinoma, Non-Small Cell Lung · Non-Small Cell Lung Cancer
United States, China, France, Germany, Italy +4 more
- A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast CancerActive Not Recruiting
Sponsor: Eli Lilly and Company
Breast Neoplasms · Neoplasm Metastasis
United States, Argentina, Australia, Austria, Belgium +17 more
- A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1)Active Not Recruiting
Sponsor: Eli Lilly and Company
Perennial Allergic Rhinitis (PAR)
United States, Belgium, China, Germany, Poland +1 more
Sponsor: Incyte Corporation
NonSegmental Vitiligo
Argentina, Austria, Belgium, Bulgaria, Denmark +9 more
- Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49)Active Not Recruiting
Sponsor: Merck Sharp & Dohme LLC
Breast Neoplasms
United States, Argentina, Australia, Austria, Brazil +26 more
Sponsor: Regeneron Pharmaceuticals
Amyotrophic Lateral Sclerosis (ALS) · Mutation in the Superoxide Dismutase-1 (SOD1) Gene
Australia, Belgium, Canada, Germany, Japan +4 more
Sponsor: Pfizer
Non-Small Cell Lung Cancer · Carcinoma, Non-Small-Cell Lung · Carcinoma, Non-Small-Cell Lung (NSCLC)
United States, Argentina, Australia, Austria, Belgium +26 more
- STOP Persistent AF PASActive Not Recruiting
Sponsor: Medtronic Cardiac Ablation Solutions
Persistent Atrial Fibrillation
United States, Austria, Germany, Italy, Poland +1 more
Sponsor: Merck Sharp & Dohme LLC
Esophageal Squamous Cell Carcinoma (ESCC) · Gastroesophageal Junction Carcinoma (GEJC) · Esophageal Adenocarcinoma (EAC)
United States, Argentina, Belgium, Brazil, Canada +22 more
- Clinical Evaluation of a Nutraceutical Supplement for Hair Growth, Hair Loss and Skin Improvement in Human VolunteersActive Not Recruiting
Sponsor: Olistic Research Labs S.L.
Early Female Pattern Hair Loss (FPHL)
Germany
- Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 MutationsActive Not Recruiting
Sponsor: Eli Lilly and Company
Acute Myeloid Leukemia (AML) · Myelodysplastic Syndrome (MDS) · Chronic Myelomonocytic Leukemia (CMML) · Myeloproliferative Neoplasms (MPNs)
United States, Australia, Belgium, Canada, Finland +7 more
Sponsor: Eledon Pharmaceuticals
Kidney Transplant Rejection
United States, Australia, Brazil, Canada, France +2 more
- A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast CancerActive Not Recruiting
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
HER2 Positive Breast Cancer
United States, Australia, Austria, Belgium, Brazil +18 more
Sponsor: Universitätsklinikum Hamburg-Eppendorf
Frailty · Frailty in Older Adults · Frailty/Sarcopenia
Germany
- Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU)Active Not Recruiting
Sponsor: Blueprint Medicines Corporation
Chronic Inducible Urticaria · Chronic Spontaneous Urticaria
United States, Denmark, Germany, Italy, Spain +1 more
Sponsor: Sanofi
Dermatitis Atopic
United States, Argentina, Australia, Brazil, Canada +10 more
- D-TECT: Pretreatment D-dimers and Disease Control in Advanced cSCC Treated With CemiplimabNot Yet Recruiting
Sponsor: Universitätsklinikum Hamburg-Eppendorf
Cutaneous Squamous Cell Carcinoma (CSCC) · Advanced Cutaneous Squamous Cell Carcinoma · Metastatic Cutaneous Squamous Cell Carcinoma
Austria, Germany
Sponsor: Carl Zeiss Meditec AG
Cataract
Czechia, Germany, Spain, United Kingdom
Sponsor: argenx
Congenital Myasthenic Syndrome
United States, Austria, Belgium, Brazil, Canada +7 more
- Study to Evaluate the Safety and Efficacy of PF-06939926 for the Treatment of Duchenne Muscular DystrophyActive Not Recruiting
Sponsor: Pfizer
Duchenne Muscular Dystrophy
United States, Australia, Belgium, Canada, France +10 more
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Carcinoma, Non-Small-Cell Lung · Squamous Cell Carcinoma of the Head and Neck · Esophageal Squamous Cell Carcinoma · Triple Negative Breast Neoplasms
United States, Belgium, Canada, China, France +6 more
Sponsor: Amgen
KRAS p, G12c Mutated /Advanced Metastatic NSCLC
United States, Australia, Belgium, Brazil, Canada +18 more
Sponsor: Takeda
Myelodysplastic Syndrome · Anemia
United States, Argentina, Australia, Belgium, Brazil +23 more